Stage 0 Breast Cancer AJCC v6 and v7
6
0
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer
Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer
SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer
Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors